A Study of Vicadrostat and Empagliflozin in Type 2 Diabetes and Cardiovascular Disease

Recruiting Phase 3 NCT07064473

Study Description

A Study to Test a New Combination Treatment for Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Study Details

Registry ID:
NCT07064473
Conditions:
Diabetes Mellitus, Type 2, Hypertension, Cardiovascular Diseases
Phase:
Phase 3
Target Enrollment:
11,800 participants
Start Date:
Healthy Volunteers:
No

Study Locations (1432 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →